Biofrontera Inc.
BFRI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001858685
No open-market purchases or sales by Biofrontera Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $2.61M in total; no superinvestor holds it.
Other share classesBFRIW
Q2 2025 vs. Q1 2025
How the institutions holding Biofrontera Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 12 | 10 | −2 |
| Shares | 1.48M | 2.04M | +562.6K (+38.0%) |
| Value | $1.18M | $1.45M | +$268.1K (+22.6%) |
New holders (2)
Institutions that held Biofrontera Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| XTX Topco Ltd | 11,561 | $8.23K | 0.00% |
| HRT Financial LP | 12,086 | $8.00K | 0.00% |
Sold out (4)
Institutions that held Biofrontera Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Citadel Advisors LLC | 28,224 | $22.6K |
| Two Sigma Securities, LLC | 11,253 | $9.00K |
| JPMorgan Chase & Co | 197 | $158 |
| Morgan Stanley | 160 | $128 |